Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,241.27
(
0.45%
)
US TECH 100
26,950.00
(
0.90%
)
Dow Jones
49,578.47
(
-0.15%
)
Brent Oil
107.50
(
-2.59%
)
Bitcoin
78,275.57
(
2.55%
)
News Focus
News Focus
Post# of 257481
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biocqr

Send PM Follow Ignore
Followers 50
Posts 3530
Boards Moderated 0
Alias Born 08/24/2005

biocqr

Member Level

Re: willyw post# 218904

Tuesday, 05/08/2018 12:00:24 PM

Tuesday, May 08, 2018 12:00:24 PM

Post# of 257481

Mavyret is still gaining market share and will likely eclipse the Gilead HCV programs.



Will that be enough of a watershed event to spur the media and analysts to generate more awareness for ENTA/Mavyret?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today